nodes	percent_of_prediction	percent_of_DWPC	metapath
Magnesium salicylate—PTGS2—Etoposide—uterine cancer	0.29	0.542	CbGbCtD
Magnesium salicylate—PTGS1—Etoposide—uterine cancer	0.245	0.458	CbGbCtD
Magnesium salicylate—Skin papilloma—Progesterone—uterine cancer	0.0212	0.0579	CcSEcCtD
Magnesium salicylate—Salicylic acid—AKR1C1—uterine cancer	0.0127	0.783	CrCbGaD
Magnesium salicylate—PTGS1—oviduct—uterine cancer	0.0117	0.143	CbGeAlD
Magnesium salicylate—Stupor—Progesterone—uterine cancer	0.00924	0.0253	CcSEcCtD
Magnesium salicylate—Heartburn—Medroxyprogesterone Acetate—uterine cancer	0.00908	0.0248	CcSEcCtD
Magnesium salicylate—PTGS1—artery—uterine cancer	0.00778	0.0946	CbGeAlD
Magnesium salicylate—Hypocalcaemia—Progesterone—uterine cancer	0.00753	0.0206	CcSEcCtD
Magnesium salicylate—PTGS2—artery—uterine cancer	0.00744	0.0904	CbGeAlD
Magnesium salicylate—Depressed level of consciousness—Progesterone—uterine cancer	0.00666	0.0182	CcSEcCtD
Magnesium salicylate—Lightheadedness—Progesterone—uterine cancer	0.00617	0.0169	CcSEcCtD
Magnesium salicylate—Hypocalcaemia—Dactinomycin—uterine cancer	0.00532	0.0146	CcSEcCtD
Magnesium salicylate—Oesophagitis—Dactinomycin—uterine cancer	0.00445	0.0122	CcSEcCtD
Magnesium salicylate—Asthma—Progesterone—uterine cancer	0.00433	0.0118	CcSEcCtD
Magnesium salicylate—Abdominal discomfort—Progesterone—uterine cancer	0.00415	0.0114	CcSEcCtD
Magnesium salicylate—Pain—Carboplatin—uterine cancer	0.004	0.011	CcSEcCtD
Magnesium salicylate—Weight increased—Progesterone—uterine cancer	0.00394	0.0108	CcSEcCtD
Magnesium salicylate—Asthma—Medroxyprogesterone Acetate—uterine cancer	0.00392	0.0107	CcSEcCtD
Magnesium salicylate—Drowsiness—Progesterone—uterine cancer	0.00386	0.0106	CcSEcCtD
Magnesium salicylate—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00376	0.0103	CcSEcCtD
Magnesium salicylate—Lethargy—Dactinomycin—uterine cancer	0.00361	0.00988	CcSEcCtD
Magnesium salicylate—PTGS2—myometrium—uterine cancer	0.00359	0.0437	CbGeAlD
Magnesium salicylate—Weight increased—Medroxyprogesterone Acetate—uterine cancer	0.00357	0.00976	CcSEcCtD
Magnesium salicylate—Body temperature decreased—Epirubicin—uterine cancer	0.00353	0.00965	CcSEcCtD
Magnesium salicylate—Hypothermia—Epirubicin—uterine cancer	0.00353	0.00965	CcSEcCtD
Magnesium salicylate—Ketoprofen—CXCL8—uterine cancer	0.0035	0.217	CrCbGaD
Magnesium salicylate—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.0035	0.00957	CcSEcCtD
Magnesium salicylate—Hepatitis—Progesterone—uterine cancer	0.00346	0.00948	CcSEcCtD
Magnesium salicylate—Gastric ulcer—Epirubicin—uterine cancer	0.0034	0.00931	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Etoposide—uterine cancer	0.00337	0.00922	CcSEcCtD
Magnesium salicylate—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.00335	0.00917	CcSEcCtD
Magnesium salicylate—Epistaxis—Medroxyprogesterone Acetate—uterine cancer	0.0033	0.00902	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Progesterone—uterine cancer	0.00327	0.00896	CcSEcCtD
Magnesium salicylate—Hypothermia—Doxorubicin—uterine cancer	0.00326	0.00893	CcSEcCtD
Magnesium salicylate—Body temperature decreased—Doxorubicin—uterine cancer	0.00326	0.00893	CcSEcCtD
Magnesium salicylate—Tinnitus—Progesterone—uterine cancer	0.00323	0.00884	CcSEcCtD
Magnesium salicylate—Oesophagitis—Etoposide—uterine cancer	0.00322	0.00882	CcSEcCtD
Magnesium salicylate—Gastric ulcer—Doxorubicin—uterine cancer	0.00315	0.00862	CcSEcCtD
Magnesium salicylate—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00314	0.00859	CcSEcCtD
Magnesium salicylate—Erythema—Progesterone—uterine cancer	0.00301	0.00825	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00297	0.00812	CcSEcCtD
Magnesium salicylate—PTGS1—epithelium—uterine cancer	0.00295	0.0359	CbGeAlD
Magnesium salicylate—PTGS1—uterine cervix—uterine cancer	0.00293	0.0355	CbGeAlD
Magnesium salicylate—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.00293	0.00801	CcSEcCtD
Magnesium salicylate—Burning sensation—Epirubicin—uterine cancer	0.00285	0.00779	CcSEcCtD
Magnesium salicylate—PTGS1—smooth muscle tissue—uterine cancer	0.00284	0.0345	CbGeAlD
Magnesium salicylate—PTGS2—epithelium—uterine cancer	0.00282	0.0343	CbGeAlD
Magnesium salicylate—PTGS2—uterine cervix—uterine cancer	0.0028	0.034	CbGeAlD
Magnesium salicylate—PTGS1—renal system—uterine cancer	0.00274	0.0333	CbGeAlD
Magnesium salicylate—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00273	0.00748	CcSEcCtD
Magnesium salicylate—PTGS2—smooth muscle tissue—uterine cancer	0.00272	0.033	CbGeAlD
Magnesium salicylate—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00267	0.00732	CcSEcCtD
Magnesium salicylate—PTGS1—endometrium—uterine cancer	0.00265	0.0322	CbGeAlD
Magnesium salicylate—Burning sensation—Doxorubicin—uterine cancer	0.00263	0.00721	CcSEcCtD
Magnesium salicylate—PTGS2—renal system—uterine cancer	0.00262	0.0318	CbGeAlD
Magnesium salicylate—PTGS1—mammalian vulva—uterine cancer	0.00256	0.0311	CbGeAlD
Magnesium salicylate—PTGS2—endometrium—uterine cancer	0.00253	0.0307	CbGeAlD
Magnesium salicylate—Confusional state—Progesterone—uterine cancer	0.00248	0.00679	CcSEcCtD
Magnesium salicylate—Oedema—Progesterone—uterine cancer	0.00246	0.00673	CcSEcCtD
Magnesium salicylate—Hepatitis—Dactinomycin—uterine cancer	0.00245	0.0067	CcSEcCtD
Magnesium salicylate—Stinging—Epirubicin—uterine cancer	0.00244	0.00668	CcSEcCtD
Magnesium salicylate—PTGS1—uterus—uterine cancer	0.00244	0.0296	CbGeAlD
Magnesium salicylate—Shock—Progesterone—uterine cancer	0.00242	0.00662	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Progesterone—uterine cancer	0.00238	0.00651	CcSEcCtD
Magnesium salicylate—Anorexia—Progesterone—uterine cancer	0.00234	0.00642	CcSEcCtD
Magnesium salicylate—PTGS2—uterus—uterine cancer	0.00233	0.0283	CbGeAlD
Magnesium salicylate—Erythema multiforme—Dactinomycin—uterine cancer	0.00231	0.00633	CcSEcCtD
Magnesium salicylate—Hypotension—Progesterone—uterine cancer	0.0023	0.00629	CcSEcCtD
Magnesium salicylate—Flushing—Dactinomycin—uterine cancer	0.00227	0.00622	CcSEcCtD
Magnesium salicylate—Stinging—Doxorubicin—uterine cancer	0.00226	0.00618	CcSEcCtD
Magnesium salicylate—ALB—lymph node—uterine cancer	0.00225	0.0273	CbGeAlD
Magnesium salicylate—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00225	0.00615	CcSEcCtD
Magnesium salicylate—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00223	0.0061	CcSEcCtD
Magnesium salicylate—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00219	0.006	CcSEcCtD
Magnesium salicylate—PTGS1—female reproductive system—uterine cancer	0.00219	0.0266	CbGeAlD
Magnesium salicylate—Somnolence—Progesterone—uterine cancer	0.00219	0.00599	CcSEcCtD
Magnesium salicylate—Dyspepsia—Progesterone—uterine cancer	0.00217	0.00593	CcSEcCtD
Magnesium salicylate—Hypocalcaemia—Epirubicin—uterine cancer	0.00216	0.00591	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00215	0.0059	CcSEcCtD
Magnesium salicylate—Decreased appetite—Progesterone—uterine cancer	0.00214	0.00585	CcSEcCtD
Magnesium salicylate—Erythema—Dactinomycin—uterine cancer	0.00213	0.00583	CcSEcCtD
Magnesium salicylate—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00212	0.00582	CcSEcCtD
Magnesium salicylate—Pain—Progesterone—uterine cancer	0.0021	0.00576	CcSEcCtD
Magnesium salicylate—Constipation—Progesterone—uterine cancer	0.0021	0.00576	CcSEcCtD
Magnesium salicylate—PTGS2—female reproductive system—uterine cancer	0.0021	0.0255	CbGeAlD
Magnesium salicylate—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00208	0.0057	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Progesterone—uterine cancer	0.00203	0.00555	CcSEcCtD
Magnesium salicylate—Hypocalcaemia—Doxorubicin—uterine cancer	0.002	0.00547	CcSEcCtD
Magnesium salicylate—PTGS1—female gonad—uterine cancer	0.00199	0.0242	CbGeAlD
Magnesium salicylate—PTGS1—vagina—uterine cancer	0.00198	0.0241	CbGeAlD
Magnesium salicylate—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00198	0.00542	CcSEcCtD
Magnesium salicylate—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00196	0.00537	CcSEcCtD
Magnesium salicylate—Urticaria—Progesterone—uterine cancer	0.00195	0.00535	CcSEcCtD
Magnesium salicylate—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00194	0.0053	CcSEcCtD
Magnesium salicylate—PTGS2—female gonad—uterine cancer	0.00191	0.0232	CbGeAlD
Magnesium salicylate—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00191	0.00522	CcSEcCtD
Magnesium salicylate—PTGS2—vagina—uterine cancer	0.00189	0.023	CbGeAlD
Magnesium salicylate—Skin exfoliation—Epirubicin—uterine cancer	0.00189	0.00517	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.00503	CcSEcCtD
Magnesium salicylate—Oesophagitis—Epirubicin—uterine cancer	0.00181	0.00494	CcSEcCtD
Magnesium salicylate—Ecchymosis—Epirubicin—uterine cancer	0.00179	0.00489	CcSEcCtD
Magnesium salicylate—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00177	0.00485	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Doxorubicin—uterine cancer	0.00175	0.00478	CcSEcCtD
Magnesium salicylate—Pruritus—Progesterone—uterine cancer	0.00174	0.00476	CcSEcCtD
Magnesium salicylate—Oedema—Dactinomycin—uterine cancer	0.00174	0.00476	CcSEcCtD
Magnesium salicylate—Diarrhoea—Progesterone—uterine cancer	0.00168	0.00461	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Etoposide—uterine cancer	0.00167	0.00458	CcSEcCtD
Magnesium salicylate—Oesophagitis—Doxorubicin—uterine cancer	0.00167	0.00458	CcSEcCtD
Magnesium salicylate—Anorexia—Dactinomycin—uterine cancer	0.00166	0.00454	CcSEcCtD
Magnesium salicylate—Ecchymosis—Doxorubicin—uterine cancer	0.00165	0.00453	CcSEcCtD
Magnesium salicylate—Flushing—Etoposide—uterine cancer	0.00164	0.0045	CcSEcCtD
Magnesium salicylate—Dizziness—Progesterone—uterine cancer	0.00163	0.00445	CcSEcCtD
Magnesium salicylate—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00158	0.00432	CcSEcCtD
Magnesium salicylate—Vomiting—Progesterone—uterine cancer	0.00156	0.00428	CcSEcCtD
Magnesium salicylate—Rash—Progesterone—uterine cancer	0.00155	0.00425	CcSEcCtD
Magnesium salicylate—Dermatitis—Progesterone—uterine cancer	0.00155	0.00424	CcSEcCtD
Magnesium salicylate—Headache—Progesterone—uterine cancer	0.00154	0.00422	CcSEcCtD
Magnesium salicylate—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.00417	CcSEcCtD
Magnesium salicylate—Decreased appetite—Dactinomycin—uterine cancer	0.00151	0.00414	CcSEcCtD
Magnesium salicylate—Dysgeusia—Etoposide—uterine cancer	0.00151	0.00413	CcSEcCtD
Magnesium salicylate—Pain—Dactinomycin—uterine cancer	0.00149	0.00407	CcSEcCtD
Magnesium salicylate—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.00403	CcSEcCtD
Magnesium salicylate—Lethargy—Epirubicin—uterine cancer	0.00146	0.00401	CcSEcCtD
Magnesium salicylate—Nausea—Progesterone—uterine cancer	0.00146	0.004	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Dactinomycin—uterine cancer	0.00143	0.00392	CcSEcCtD
Magnesium salicylate—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00388	CcSEcCtD
Magnesium salicylate—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.00385	CcSEcCtD
Magnesium salicylate—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.00384	CcSEcCtD
Magnesium salicylate—Headache—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.00382	CcSEcCtD
Magnesium salicylate—Lethargy—Doxorubicin—uterine cancer	0.00136	0.00371	CcSEcCtD
Magnesium salicylate—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00132	0.00362	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Epirubicin—uterine cancer	0.00131	0.00359	CcSEcCtD
Magnesium salicylate—PTGS1—lymph node—uterine cancer	0.00128	0.0156	CbGeAlD
Magnesium salicylate—Confusional state—Etoposide—uterine cancer	0.00127	0.00347	CcSEcCtD
Magnesium salicylate—Asthma—Epirubicin—uterine cancer	0.00124	0.00339	CcSEcCtD
Magnesium salicylate—PTGS2—lymph node—uterine cancer	0.00123	0.0149	CbGeAlD
Magnesium salicylate—Hyperhidrosis—Etoposide—uterine cancer	0.00122	0.00333	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Doxorubicin—uterine cancer	0.00121	0.00332	CcSEcCtD
Magnesium salicylate—Anorexia—Etoposide—uterine cancer	0.0012	0.00328	CcSEcCtD
Magnesium salicylate—Diarrhoea—Dactinomycin—uterine cancer	0.00119	0.00326	CcSEcCtD
Magnesium salicylate—Hypotension—Etoposide—uterine cancer	0.00118	0.00322	CcSEcCtD
Magnesium salicylate—Asthma—Doxorubicin—uterine cancer	0.00115	0.00314	CcSEcCtD
Magnesium salicylate—Weight increased—Epirubicin—uterine cancer	0.00113	0.00309	CcSEcCtD
Magnesium salicylate—Somnolence—Etoposide—uterine cancer	0.00112	0.00306	CcSEcCtD
Magnesium salicylate—Drowsiness—Epirubicin—uterine cancer	0.00111	0.00303	CcSEcCtD
Magnesium salicylate—Vomiting—Dactinomycin—uterine cancer	0.00111	0.00303	CcSEcCtD
Magnesium salicylate—Rash—Dactinomycin—uterine cancer	0.0011	0.003	CcSEcCtD
Magnesium salicylate—Decreased appetite—Etoposide—uterine cancer	0.00109	0.00299	CcSEcCtD
Magnesium salicylate—Constipation—Etoposide—uterine cancer	0.00108	0.00295	CcSEcCtD
Magnesium salicylate—Pain—Etoposide—uterine cancer	0.00108	0.00295	CcSEcCtD
Magnesium salicylate—Sweating—Epirubicin—uterine cancer	0.00106	0.0029	CcSEcCtD
Magnesium salicylate—Weight increased—Doxorubicin—uterine cancer	0.00104	0.00286	CcSEcCtD
Magnesium salicylate—Epistaxis—Epirubicin—uterine cancer	0.00104	0.00286	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Etoposide—uterine cancer	0.00104	0.00284	CcSEcCtD
Magnesium salicylate—Nausea—Dactinomycin—uterine cancer	0.00103	0.00283	CcSEcCtD
Magnesium salicylate—Drowsiness—Doxorubicin—uterine cancer	0.00102	0.0028	CcSEcCtD
Magnesium salicylate—Urticaria—Etoposide—uterine cancer	0.001	0.00274	CcSEcCtD
Magnesium salicylate—Hepatitis—Epirubicin—uterine cancer	0.000993	0.00272	CcSEcCtD
Magnesium salicylate—Sweating—Doxorubicin—uterine cancer	0.000981	0.00269	CcSEcCtD
Magnesium salicylate—Epistaxis—Doxorubicin—uterine cancer	0.000965	0.00264	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Epirubicin—uterine cancer	0.000939	0.00257	CcSEcCtD
Magnesium salicylate—Tinnitus—Epirubicin—uterine cancer	0.000926	0.00253	CcSEcCtD
Magnesium salicylate—Flushing—Epirubicin—uterine cancer	0.000921	0.00252	CcSEcCtD
Magnesium salicylate—Hepatitis—Doxorubicin—uterine cancer	0.000919	0.00251	CcSEcCtD
Magnesium salicylate—Pruritus—Etoposide—uterine cancer	0.00089	0.00244	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Doxorubicin—uterine cancer	0.000869	0.00238	CcSEcCtD
Magnesium salicylate—Erythema—Epirubicin—uterine cancer	0.000864	0.00237	CcSEcCtD
Magnesium salicylate—Diarrhoea—Etoposide—uterine cancer	0.000861	0.00236	CcSEcCtD
Magnesium salicylate—Tinnitus—Doxorubicin—uterine cancer	0.000857	0.00234	CcSEcCtD
Magnesium salicylate—Flushing—Doxorubicin—uterine cancer	0.000853	0.00233	CcSEcCtD
Magnesium salicylate—Dysgeusia—Epirubicin—uterine cancer	0.000846	0.00232	CcSEcCtD
Magnesium salicylate—Dizziness—Etoposide—uterine cancer	0.000832	0.00228	CcSEcCtD
Magnesium salicylate—Vomiting—Etoposide—uterine cancer	0.0008	0.00219	CcSEcCtD
Magnesium salicylate—Erythema—Doxorubicin—uterine cancer	0.0008	0.00219	CcSEcCtD
Magnesium salicylate—Rash—Etoposide—uterine cancer	0.000793	0.00217	CcSEcCtD
Magnesium salicylate—Dermatitis—Etoposide—uterine cancer	0.000793	0.00217	CcSEcCtD
Magnesium salicylate—Headache—Etoposide—uterine cancer	0.000788	0.00216	CcSEcCtD
Magnesium salicylate—Dysgeusia—Doxorubicin—uterine cancer	0.000783	0.00214	CcSEcCtD
Magnesium salicylate—Nausea—Etoposide—uterine cancer	0.000747	0.00205	CcSEcCtD
Magnesium salicylate—Confusional state—Epirubicin—uterine cancer	0.000711	0.00195	CcSEcCtD
Magnesium salicylate—Oedema—Epirubicin—uterine cancer	0.000705	0.00193	CcSEcCtD
Magnesium salicylate—Shock—Epirubicin—uterine cancer	0.000694	0.0019	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Epirubicin—uterine cancer	0.000682	0.00187	CcSEcCtD
Magnesium salicylate—Anorexia—Epirubicin—uterine cancer	0.000672	0.00184	CcSEcCtD
Magnesium salicylate—Hypotension—Epirubicin—uterine cancer	0.000659	0.0018	CcSEcCtD
Magnesium salicylate—Confusional state—Doxorubicin—uterine cancer	0.000658	0.0018	CcSEcCtD
Magnesium salicylate—Oedema—Doxorubicin—uterine cancer	0.000653	0.00179	CcSEcCtD
Magnesium salicylate—Shock—Doxorubicin—uterine cancer	0.000642	0.00176	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Doxorubicin—uterine cancer	0.000631	0.00173	CcSEcCtD
Magnesium salicylate—Somnolence—Epirubicin—uterine cancer	0.000627	0.00172	CcSEcCtD
Magnesium salicylate—Anorexia—Doxorubicin—uterine cancer	0.000622	0.0017	CcSEcCtD
Magnesium salicylate—Dyspepsia—Epirubicin—uterine cancer	0.000621	0.0017	CcSEcCtD
Magnesium salicylate—Decreased appetite—Epirubicin—uterine cancer	0.000613	0.00168	CcSEcCtD
Magnesium salicylate—Hypotension—Doxorubicin—uterine cancer	0.00061	0.00167	CcSEcCtD
Magnesium salicylate—Constipation—Epirubicin—uterine cancer	0.000603	0.00165	CcSEcCtD
Magnesium salicylate—Pain—Epirubicin—uterine cancer	0.000603	0.00165	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Epirubicin—uterine cancer	0.000581	0.00159	CcSEcCtD
Magnesium salicylate—Somnolence—Doxorubicin—uterine cancer	0.00058	0.00159	CcSEcCtD
Magnesium salicylate—Dyspepsia—Doxorubicin—uterine cancer	0.000575	0.00157	CcSEcCtD
Magnesium salicylate—Decreased appetite—Doxorubicin—uterine cancer	0.000567	0.00155	CcSEcCtD
Magnesium salicylate—Urticaria—Epirubicin—uterine cancer	0.00056	0.00153	CcSEcCtD
Magnesium salicylate—Pain—Doxorubicin—uterine cancer	0.000558	0.00153	CcSEcCtD
Magnesium salicylate—Constipation—Doxorubicin—uterine cancer	0.000558	0.00153	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Doxorubicin—uterine cancer	0.000538	0.00147	CcSEcCtD
Magnesium salicylate—Urticaria—Doxorubicin—uterine cancer	0.000519	0.00142	CcSEcCtD
Magnesium salicylate—Pruritus—Epirubicin—uterine cancer	0.000499	0.00137	CcSEcCtD
Magnesium salicylate—Diarrhoea—Epirubicin—uterine cancer	0.000483	0.00132	CcSEcCtD
Magnesium salicylate—Dizziness—Epirubicin—uterine cancer	0.000466	0.00128	CcSEcCtD
Magnesium salicylate—Pruritus—Doxorubicin—uterine cancer	0.000462	0.00126	CcSEcCtD
Magnesium salicylate—Vomiting—Epirubicin—uterine cancer	0.000449	0.00123	CcSEcCtD
Magnesium salicylate—Diarrhoea—Doxorubicin—uterine cancer	0.000447	0.00122	CcSEcCtD
Magnesium salicylate—Rash—Epirubicin—uterine cancer	0.000445	0.00122	CcSEcCtD
Magnesium salicylate—Dermatitis—Epirubicin—uterine cancer	0.000444	0.00122	CcSEcCtD
Magnesium salicylate—Headache—Epirubicin—uterine cancer	0.000442	0.00121	CcSEcCtD
Magnesium salicylate—Dizziness—Doxorubicin—uterine cancer	0.000432	0.00118	CcSEcCtD
Magnesium salicylate—Nausea—Epirubicin—uterine cancer	0.000419	0.00115	CcSEcCtD
Magnesium salicylate—Vomiting—Doxorubicin—uterine cancer	0.000415	0.00114	CcSEcCtD
Magnesium salicylate—Rash—Doxorubicin—uterine cancer	0.000412	0.00113	CcSEcCtD
Magnesium salicylate—Dermatitis—Doxorubicin—uterine cancer	0.000411	0.00113	CcSEcCtD
Magnesium salicylate—Headache—Doxorubicin—uterine cancer	0.000409	0.00112	CcSEcCtD
Magnesium salicylate—Nausea—Doxorubicin—uterine cancer	0.000388	0.00106	CcSEcCtD
Magnesium salicylate—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—AKR1C3—uterine cancer	5.19e-05	0.0677	CbGpPWpGaD
Magnesium salicylate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFE2L2—uterine cancer	4.42e-05	0.0577	CbGpPWpGaD
Magnesium salicylate—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—AKR1C3—uterine cancer	4.12e-05	0.0537	CbGpPWpGaD
Magnesium salicylate—PTGS1—Prostaglandin Synthesis and Regulation—CYP11A1—uterine cancer	2.99e-05	0.039	CbGpPWpGaD
Magnesium salicylate—PTGS2—Prostaglandin Synthesis and Regulation—CYP11A1—uterine cancer	2.37e-05	0.0309	CbGpPWpGaD
Magnesium salicylate—ALB—Bile acid and bile salt metabolism—AKR1C1—uterine cancer	2.03e-05	0.0265	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—NFE2L2—uterine cancer	1.9e-05	0.0248	CbGpPWpGaD
Magnesium salicylate—PTGS1—Arachidonic acid metabolism—AKR1C3—uterine cancer	1.87e-05	0.0244	CbGpPWpGaD
Magnesium salicylate—ALB—Bile acid and bile salt metabolism—AKR1C3—uterine cancer	1.57e-05	0.0204	CbGpPWpGaD
Magnesium salicylate—PTGS2—Arachidonic acid metabolism—AKR1C3—uterine cancer	1.49e-05	0.0194	CbGpPWpGaD
Magnesium salicylate—PTGS1—Overview of nanoparticle effects—CXCL8—uterine cancer	1.47e-05	0.0192	CbGpPWpGaD
Magnesium salicylate—PTGS1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	1.39e-05	0.0181	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—GPX3—uterine cancer	1.36e-05	0.0177	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	1.31e-05	0.0171	CbGpPWpGaD
Magnesium salicylate—PTGS2—Overview of nanoparticle effects—CXCL8—uterine cancer	1.17e-05	0.0152	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—GPX3—uterine cancer	1.1e-05	0.0143	CbGpPWpGaD
Magnesium salicylate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—uterine cancer	1.09e-05	0.0142	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—GPX3—uterine cancer	1.08e-05	0.0141	CbGpPWpGaD
Magnesium salicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—uterine cancer	1.03e-05	0.0134	CbGpPWpGaD
Magnesium salicylate—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.02e-05	0.0133	CbGpPWpGaD
Magnesium salicylate—PTGS2—S1P1 pathway—VEGFA—uterine cancer	9.49e-06	0.0124	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—GPX3—uterine cancer	8.73e-06	0.0114	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	8.27e-06	0.0108	CbGpPWpGaD
Magnesium salicylate—PTGS1—Biological oxidations—CYP11A1—uterine cancer	7.38e-06	0.00963	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	7.34e-06	0.00958	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—MTHFR—uterine cancer	6.98e-06	0.0091	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—MTHFR—uterine cancer	6.93e-06	0.00905	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	6.56e-06	0.00855	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—MTHFR—uterine cancer	5.64e-06	0.00736	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	5.62e-06	0.00734	CbGpPWpGaD
Magnesium salicylate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—uterine cancer	5.59e-06	0.00729	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—MTHFR—uterine cancer	5.54e-06	0.00723	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—CCL2—uterine cancer	5.46e-06	0.00712	CbGpPWpGaD
Magnesium salicylate—PTGS1—Biological oxidations—CYP19A1—uterine cancer	5.43e-06	0.00709	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—CCL2—uterine cancer	5.43e-06	0.00708	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—uterine cancer	5.39e-06	0.00703	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	5.2e-06	0.00679	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	4.94e-06	0.00644	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.74e-06	0.00618	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.74e-06	0.00618	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	4.71e-06	0.00615	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	4.68e-06	0.0061	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	4.62e-06	0.00603	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—MTHFR—uterine cancer	4.48e-06	0.00585	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—CCL2—uterine cancer	4.41e-06	0.00576	CbGpPWpGaD
Magnesium salicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—uterine cancer	4.4e-06	0.00574	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	4.37e-06	0.0057	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—CCL2—uterine cancer	4.34e-06	0.00566	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	4.21e-06	0.00549	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	3.98e-06	0.00519	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	3.97e-06	0.00517	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—CDKN2A—uterine cancer	3.92e-06	0.00512	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.76e-06	0.00491	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.76e-06	0.00491	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	3.56e-06	0.00464	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—CCL2—uterine cancer	3.51e-06	0.00458	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.48e-06	0.00454	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—CDKN1B—uterine cancer	3.47e-06	0.00453	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CCL2—uterine cancer	3.43e-06	0.00447	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	3.38e-06	0.00441	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—EP300—uterine cancer	3.05e-06	0.00398	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.04e-06	0.00397	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.04e-06	0.00397	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—SRD5A2—uterine cancer	2.92e-06	0.00381	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—NDUFB11—uterine cancer	2.92e-06	0.00381	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—ABCC9—uterine cancer	2.89e-06	0.00378	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—NRAS—uterine cancer	2.85e-06	0.00372	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.84e-06	0.0037	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.76e-06	0.0036	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CXCL8—uterine cancer	2.71e-06	0.00354	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.68e-06	0.00349	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	2.65e-06	0.00346	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CDKN1B—uterine cancer	2.65e-06	0.00345	CbGpPWpGaD
Magnesium salicylate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	2.5e-06	0.00326	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—KRAS—uterine cancer	2.46e-06	0.0032	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—VEGFA—uterine cancer	2.43e-06	0.00317	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SRD5A2—uterine cancer	2.32e-06	0.00302	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—NDUFB11—uterine cancer	2.32e-06	0.00302	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	2.32e-06	0.00302	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.25e-06	0.00294	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.23e-06	0.00291	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—AKR1B10—uterine cancer	2.15e-06	0.00281	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—TP53—uterine cancer	2.14e-06	0.00279	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.13e-06	0.00277	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—AKR1B1—uterine cancer	2.11e-06	0.00275	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—STAR—uterine cancer	2.11e-06	0.00275	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—HRAS—uterine cancer	2.09e-06	0.00272	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.09e-06	0.00272	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.94e-06	0.00254	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IRF1—uterine cancer	1.88e-06	0.00245	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SRD5A2—uterine cancer	1.87e-06	0.00245	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NDUFB11—uterine cancer	1.87e-06	0.00245	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.82e-06	0.00238	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.8e-06	0.00235	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—RNF43—uterine cancer	1.78e-06	0.00233	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.72e-06	0.00224	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.7e-06	0.00222	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—AKR1B1—uterine cancer	1.68e-06	0.00219	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—STAR—uterine cancer	1.68e-06	0.00219	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TP53—uterine cancer	1.66e-06	0.00217	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.66e-06	0.00216	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—POLD1—uterine cancer	1.66e-06	0.00216	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.66e-06	0.00216	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.58e-06	0.00206	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—AKR1C1—uterine cancer	1.55e-06	0.00202	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.5e-06	0.00195	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—AKR1C1—uterine cancer	1.47e-06	0.00192	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—RRM2—uterine cancer	1.38e-06	0.0018	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—AKR1B1—uterine cancer	1.36e-06	0.00177	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—STAR—uterine cancer	1.36e-06	0.00177	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—DCN—uterine cancer	1.34e-06	0.00175	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.34e-06	0.00175	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—POLD1—uterine cancer	1.31e-06	0.00172	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.27e-06	0.00166	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—DCN—uterine cancer	1.27e-06	0.00166	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP11A1—uterine cancer	1.26e-06	0.00165	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—AKR1C1—uterine cancer	1.23e-06	0.0016	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—AKR1C3—uterine cancer	1.19e-06	0.00156	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.17e-06	0.00153	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.13e-06	0.00148	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—AKR1C3—uterine cancer	1.13e-06	0.00147	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HMGA1—uterine cancer	1.1e-06	0.00144	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—RRM2—uterine cancer	1.1e-06	0.00143	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	1.08e-06	0.00141	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—DCN—uterine cancer	1.06e-06	0.00139	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—POLD1—uterine cancer	1.06e-06	0.00139	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FBXW7—uterine cancer	1.01e-06	0.00131	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP11A1—uterine cancer	1e-06	0.00131	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—AKR1C1—uterine cancer	9.95e-07	0.0013	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	9.56e-07	0.00125	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—AKR1C3—uterine cancer	9.47e-07	0.00124	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—STK11—uterine cancer	9.29e-07	0.00121	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP19A1—uterine cancer	9.29e-07	0.00121	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—RRM2—uterine cancer	8.87e-07	0.00116	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.72e-07	0.00114	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—DCN—uterine cancer	8.61e-07	0.00112	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	8.42e-07	0.0011	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.32e-07	0.00109	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP11A1—uterine cancer	8.11e-07	0.00106	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CDKN2B—uterine cancer	7.89e-07	0.00103	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—AKR1C3—uterine cancer	7.66e-07	0.000999	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—STK11—uterine cancer	7.38e-07	0.000962	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP19A1—uterine cancer	7.38e-07	0.000962	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SMAD3—uterine cancer	7.21e-07	0.00094	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—MTHFR—uterine cancer	6.98e-07	0.000911	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.92e-07	0.000903	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	6.88e-07	0.000897	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FGFR2—uterine cancer	6.88e-07	0.000897	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MTHFR—uterine cancer	6.62e-07	0.000863	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.6e-07	0.000861	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.15e-07	0.000803	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—STK11—uterine cancer	5.97e-07	0.000779	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP19A1—uterine cancer	5.97e-07	0.000779	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—EP300—uterine cancer	5.87e-07	0.000766	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.6e-07	0.000731	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—VEGFA—uterine cancer	5.56e-07	0.000725	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—MTHFR—uterine cancer	5.54e-07	0.000723	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—NRAS—uterine cancer	5.49e-07	0.000716	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.34e-07	0.000697	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.88e-07	0.000637	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—KRAS—uterine cancer	4.72e-07	0.000616	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—MTHFR—uterine cancer	4.48e-07	0.000585	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CA—uterine cancer	4.34e-07	0.000566	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ERBB2—uterine cancer	4.32e-07	0.000563	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TP53—uterine cancer	4.2e-07	0.000548	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—HRAS—uterine cancer	4.02e-07	0.000524	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CDKN1B—uterine cancer	4e-07	0.000522	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.95e-07	0.000516	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PTEN—uterine cancer	3.88e-07	0.000507	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CTNNB1—uterine cancer	3.78e-07	0.000493	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—EP300—uterine cancer	3.7e-07	0.000483	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PTEN—uterine cancer	3.68e-07	0.00048	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—AKT1—uterine cancer	3.55e-07	0.000463	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—EP300—uterine cancer	3.51e-07	0.000458	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NRAS—uterine cancer	3.28e-07	0.000429	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PTEN—uterine cancer	3.08e-07	0.000402	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—EP300—uterine cancer	2.94e-07	0.000384	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—KRAS—uterine cancer	2.83e-07	0.000369	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CA—uterine cancer	2.74e-07	0.000357	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3CA—uterine cancer	2.6e-07	0.000339	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PTEN—uterine cancer	2.49e-07	0.000325	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HRAS—uterine cancer	2.4e-07	0.000314	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—EP300—uterine cancer	2.38e-07	0.00031	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—AKT1—uterine cancer	2.24e-07	0.000292	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CA—uterine cancer	2.18e-07	0.000284	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—AKT1—uterine cancer	2.12e-07	0.000277	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—AKT1—uterine cancer	1.78e-07	0.000232	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CA—uterine cancer	1.76e-07	0.00023	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—AKT1—uterine cancer	1.44e-07	0.000188	CbGpPWpGaD
